Laporan Kasus: Terapi Covid-19 pada Pasien dengan Komorbid Hipertensi
Case Report: Covid-19 Therapy in Patients with Comorbid Hypertension
Keywords:
Terapi, COVID-19, Komorbid, HipertensiAbstract
References
B. Damle, M. Vourvahis, E. Wang, J. Leaney, & B. Corrigan, Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19. Clinical Pharmacology and Therapeutics, 108 (2020) 201–211. https://doi.org/10.1002/cpt.1857.
E. Burhan, A. Dwi Susanto, F. Isbaniah, S. Aman Nasution, E. Ginanjar, C. Wicaksono Pitoyo, A. Susilo, I. Firdaus, A. Santoso, D. Arifa Juzar, S. Kamsul Arif, N. G. Lolong Wulung, F. Muchtar, A. B. Pulungan, H. Ambara Sjakti, Y. Prawira, N. Dwi Putri TIM PENYUSUN Erlina Burhan, D. Adityaningsih, A. Fahrial Syam, M. Rasmin, I. Rengganis, L. Sukrisman, T. Damayanti, W. Heru Wiyono, M. Elhidsi, W. Aniwidyaningsih, D. Handayani, J. R. Sugiri, E. Rizal Wahyudi, N. Ayu Mulansari, T. Juli Edi Tarigan, R. Hidayat, C. Martin Rumende, A. Yuwono Soeroto, E. Astha Triyono, S. Katu, P. Agustina, D. Puspitorini, I. Prasetya Wijaya, T. Musbah, A. H. Pudjiadi, P. B. Yanuarso, A. Alam, N. Kaswandani, N. Dwi Putri, K. Taufiq Kadafi, R. D. Roeslaini, & C. Mayung Sambo, PEDOMAN TATALAKSANA COVID-19 Edisi 3 TIM EDITOR Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN) Ikatan Dokter Anak Indonesia (IDAI) (2020).
P. Sun, X. Lu, C. Xu, W. Sun, & B. Pan, Understanding of COVID-19 based on current evidence. Journal of Medical Virology, 92 (2020) 548–551. https://doi.org/10.1002/jmv.25722.
BPOM, Pedoman Pelayanan Publik di Bidang Obat Dalam Kondisi Pandemi COVID-19 (2020).
A. C. Fears, R. F. Garry, C. J. Roy, D. S. Reed, W. B. Klimstra, P. Duprex, A. Hartman, S. C. Weaver, K. C. Plante, D. Mirchandani, J. A. Plante, P. v. Aguilar, D. Fernández, A. Nalca, A. Totura, D. Dyer, B. Kearney, M. Lackemeyer, J. K. Bohannon, & R. Johnson, Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions. medRxiv?: the preprint server for health sciences, (2020). https://doi.org/10.1101/2020.04.13.20063784.
F. E. P. van Dooren, G. Nefs, M. T. Schram, F. R. J. Verhey, J. Denollet, & F. Pouwer, Depression and Risk of Mortality in People with Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS ONE, 8 (2013). https://doi.org/10.1371/journal.pone.0057058.
P. S. S. A. A. S. K. H. S Kannan, COVID-19 (Novel Coronavirus 2019) – recent trends. European Review for Medical and Pharmacological Sciences, (2020).
C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, & B. Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395 (2020) 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.
R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W. J. Liu, D. Wang, W. Xu, E. C. Holmes, G. F. Gao, G. Wu, W. Chen, W. Shi, & W. Tan, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395 (2020) 565–574. https://doi.org/10.1016/S0140-6736(20)30251-8.
[10]. W. Guan, Z. Ni, Y. Hu, W. Liang, C. Ou, J. He, L. Liu, H. Shan, C. Lei, D. S. C. Hui, B. Du, L. Li, G. Zeng, K.-Y. Yuen, R. Chen, C. Tang, T. Wang, P. Chen, J. Xiang, S. Li, J. Wang, Z. Liang, Y. Peng, L. Wei, Y. Liu, Y. Hu, P. Peng, J. Wang, J. Liu, Z. Chen, G. Li, Z. Zheng, S. Qiu, J. Luo, C. Ye, S. Zhu, & N. Zhong, Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382 (2020) 1708–1720. https://doi.org/10.1056/nejmoa2002032.
A. P. Setiadi, Y. I. Wibowo, S. v. Halim, C. Brata, B. Presley, & E. Setiawan, Tata Laksana Terapi Pasien dengan COVID-19: Sebuah Kajian Naratif. Indonesian Journal of Clinical Pharmacy, 9 (2020) 70. https://doi.org/10.15416/ijcp.2020.9.1.70.
C. A. Devaux, J. M. Rolain, P. Colson, & D. Raoult, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? International Journal of Antimicrobial Agents, 55 (2020). https://doi.org/10.1016/j.ijantimicag.2020.105938.
A. P. Singh, S. Tousif, P. Umbarkar, & H. Lal, A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation. Journal of Clinical Medicine, 9 (2020) 1867. https://doi.org/10.3390/jcm9061867.
Y. Wang, F. Zhou, D. Zhang, J. Zhao, R. Du, Y. Hu, Z. Cheng, L. Gao, Y. Jin, G. Luo, S. Fu, Q. Lu, G. Du, K. Wang, Y. Lu, G. Fan, Y. Zhang, Y. Liu, S. Ruan, W. Liu, T. Jaki, F. G. Hayden, P. W. Horby, B. Cao, & C. Wang, Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: Study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials, 21 (2020). https://doi.org/10.1186/s13063-020-04352-9.
J. Geleris, Y. Sun, J. Platt, J. Zucker, M. Baldwin, G. Hripcsak, A. Labella, D. K. Manson, C. Kubin, R. G. Barr, M. E. Sobieszczyk, & N. W. Schluger, Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine, 382 (2020) 2411–2418. https://doi.org/10.1056/nejmoa2012410.
H. Fares, J. J. Dinicolantonio, J. H. O’keefe, & C. J. Lavie, Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Openheart, (n.d.). https://doi.org/10.1136/openhrt-2016.